3101 - 3125 of 8587 Results
Title
Year
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry2014OPENTitle: Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass SpectrometryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/srep05797Best OA location URL: https://www.nature.com/articles/srep05797.pdfCitation Count: 155
- Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model2018OPENTitle: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0062-4Best OA location URL: https://www.nature.com/articles/s41531-018-0062-4.pdfCitation Count: 78
-
OPENTitle: Prevalence of Parkinson’s disease across North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0058-0Best OA location URL: https://escholarship.org/uc/item/1qs1g07mCitation Count: 844
-
OPENTitle: LRRK2 levels in immune cells are increased in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0010-8Best OA location URL: https://www.nature.com/articles/s41531-017-0010-8.pdfCitation Count: 237
-
OPENTitle: Neurologist care in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 851End Page: 857Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c9123Best OA location URL: https://n.neurology.org/content/neurology/77/9/851.full.pdfCitation Count: 265
-
OPENTitle: “On” state freezing of gait in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 7Start Page: 454End Page: 457Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182477ec0Citation Count: 201
-
OPENTitle: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 597End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443Best OA location URL: https://n.neurology.org/content/neurology/79/6/597.full.pdfCitation Count: 159
- The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling2012OPENTitle: The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor SignalingJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 6Start Page: e39132End Page: e39132Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0039132Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0039132&type=printableCitation Count: 205
-
OPENTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3419487Citation Count: 38
- Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study2014OPENTitle: Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography studyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 112Issue #: 7Start Page: 1739End Page: 1747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00383.2014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4157173Citation Count: 82
-
OPENTitle: Sarcopenia and impairment in cognitive and physical performanceJournal Name: Clinical Interventions in AgingPublisher: Informa UK LimitedVol:Issue #:Start Page: 663End Page: 663Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cia.s76275Best OA location URL: https://www.dovepress.com/getfile.php?fileID=24358Citation Count: 98
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo2014OPENTitle: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 5Start Page: 1496End Page: 1513Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu057Best OA location URL: https://academic.oup.com/brain/article-pdf/137/5/1496/11140606/awu057.pdfCitation Count: 218
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4120020Citation Count: 74
-
OPENTitle: Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gaitJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1624Issue #:Start Page: 222End Page: 231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2015.07.041Best OA location URL: http://doi.org/10.1016/j.brainres.2015.07.041Citation Count: 27
-
OPENTitle: Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 132Issue #: 7Start Page: 1783End Page: 1794Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awp044Best OA location URL: https://academic.oup.com/brain/article-pdf/132/7/1783/13734818/awp044.pdfCitation Count: 656
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis2010OPENTitle: Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisJournal Name: NeuronPublisher: Elsevier BVVol: 65Issue #: 1Start Page: 66End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2009.12.023Best OA location URL: http://www.cell.com/article/S0896627309010411/pdfCitation Count: 972
- Sonic Hedgehog Maintains Cellular and Neurochemical Homeostasis in the Adult Nigrostriatal Circuit2012OPENTitle: Sonic Hedgehog Maintains Cellular and Neurochemical Homeostasis in the Adult Nigrostriatal CircuitJournal Name: NeuronPublisher: Elsevier BVVol: 75Issue #: 2Start Page: 306End Page: 319Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2012.05.018Best OA location URL: http://www.cell.com/article/S0896627312004849/pdfCitation Count: 157
-
OPENTitle: Longitudinal study of normal cognition in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 15Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002001Best OA location URL: https://n.neurology.org/content/neurology/85/15/1276.full.pdfCitation Count: 226
- Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in Rats2011OPENTitle: Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in RatsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 1106End Page: 1110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm101271sCitation Count: 48
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qCitation Count: 59
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease2011OPENTitle: Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 33Issue #: 9Start Page: 1598End Page: 1610Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2011.07660.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3086951Citation Count: 118
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells2011OPENTitle: α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cellsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 2Start Page: 715End Page: 725Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43366Best OA location URL: http://resolver.sub.uni-goettingen.de/purl?gs-1/7841Citation Count: 789
- Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation2009OPENTitle: Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradationJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 119Issue #: 3Start Page: 650End Page: 660Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci37617Best OA location URL: http://doi.org/10.1172/JCI37617Citation Count: 376
- Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology2012OPENTitle: Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathologyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms2032Best OA location URL: https://www.nature.com/articles/ncomms2032.pdfCitation Count: 135
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies2015OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 137